Clinical trial
Humanized Anti-Tac Antibody Therapy In Hodgkin's Disease, A Phase Ib/II Trial
NCT00002681 is registered in ClinicalTrials.gov with Roger Williams Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Humanized Anti-Tac Antibody Therapy In Hodgkin's Disease, A Phase Ib/II Trial
- Lead sponsor
- Roger Williams Medical Center
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- July 31, 1995
- Completion date
- December 31, 2003
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.